Johannes Aufenanger, Michael Samman, Michael Quintel, Klaus Fassbender, Wilma Zimmer, Thomas Bertsch
Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk
Remarkably elevated levels of phospholipase A2 (PLA2)
are measurable in human blood samples in cases of
acute pancreatitis. The source of the enzyme was first
thought to be exclusively the pancreas, but now it is
generally accepted that two isoenzymes – the pancreatic
PLA2, group I, and the extrapancreatic PLA2, group
II – contribute to the raised activity. In contrast to the
group II-PLA2, the pancreatic PLA2 is heat-resistant for
1 hour at 60 °C. The catalytically inactive proenzyme of
the pancreatic PLA2 can be activated by trypsin. The
aim of our study was to evaluate the diagnostic value
of PLA2 isoenzyme activity measurements to identify
patients with severe complications in acute pancreatitis.
Blood samples from patients suffering from acute
pancreatitis were analyzed for catalytically active pancreatic
PLA2 on day 1 and 2 of hospitalization with a
modified radiometric Escherichia coli-based PLA2 assay.
In 10 of 41 patients clearly elevated values of catalytically
active, heat-resistant pancreatic PLA2 (7.2 to
81.2 U/l) were observed. This group of patients was
characterized by severe complications (necrotizing
pancreatitis, shock, sepsis, respiratory problems) of
which two patients subsequently died. Patients with
low or undetectable activity (<7 U/l) of pancreatic PLA2
recovered rapidly. According to these results the presence
of catalytically active pancreatic PLA2 in serum is
associated with severe complications of acute pancreatitis.
In contrast to total serum-PLA2, the catalytic
concentration of pancreatic PLA2 can serve as a prognostic
marker in acute pancreatitis.
Clinical Chemical Laboratory Medicine, Walter de Gruyter
Print ISSN: 1434-6621
Volume: 40, 04/2002
Pages: 293 - 297
Show full article (external site)
Show all available items of this journal